SEARCH

SEARCH BY CITATION

References

  • Appignani, B., Bhadelia, R., Blacklow, S., Wang, A., Roland, S. & Freeman, R. (1996) Neuroimaging findings in patients on immunosuppressive therapy: experience with tacrolimus toxicity. American Journal of Radiology, 166, 683688.
  • Atkinson, K., Biggs, J., Darveniza, P., Boland, J., Concannon, A. & Dodds, A. (1984) Cyclosporin-associated central nervous system toxicity after allogeneic bone marrow transplantation. Transplantation, 38, 3437.
  • Bartynski, W.S., Zeigler, Z., Spearman, M.P., Lin, L., Shadduck, R.K. & Lister, J. (2001) Etiology of cortical and white matter lesions in cyclosporin-A and FK-506 neurotoxicity. American Journal of Neuroradiology, 22, 19011914.
  • Bechstein, W.O. (2000) Neurotoxicity of calcineurin inhibitors: impact and clinical management. Transplant International, 13, 313326.
  • Bova, D., Shownkeen, H., Goldberg, K., Horowitz, S. & Azar-Kia, B. (2000) Delayed transient neurologic toxicity due to tacrolimus: CT and MRI. Neuroradiology, 42, 666668.
  • Devine, S.M., Newman, N.J., Siegel, J.L., Joseph, G.J., Geis, T.C., Schneider, J.A., Geller, R.B. & Wingard, J.R. (1996) Tacrolimus (FK506)-induced cerebral blindness following bone marrow transplantation. Bone Marrow Transplantation, 18, 569572.
  • Eidelman, B.H., Abu-Elmagd, K., Wilson, J., Fung, J.J., Alessiani, M., Jain, A., Takaya, S., Todo, S.N., Tzakis, A., Van Thiel, D., Shannon, W. & Starzl, T.E. (1991) Neurologic complications of FK 506. Transplantation Proceedings, 23, 31753178.
  • Erer, B., Polchi, P., Lucarelli, G., Angelucci, E., Baronciani, D., Galimberti, M., Giardini, C., Gaziev, D. & Maiello, A. (1996) CsA-associated neurotoxicity and ineffective prophylaxis with clonazepam in patients transplanted for thalassemia major: analysis of risk factors. Bone Marrow Transplantation, 18, 157162.
  • Fryer, J.P., Fortier, M.V., Metrakos, P., Verran, D.J., Asfar, S.K., Pelz, D.M., Wall, W.J., Grant, D.R. & Ghent, C.N. (1996) Central pontine myelinolysis and cyclosporine neurotoxicity following liver transplantation. Transplantation, 61, 658661.
  • Fung, J.J., Alessiani, M., Abu-Elmagd, K., Todo, S., Shapiro, R., Tzakis, A., Van Thiel, D., Armitage, J., Jain, A., McCauley, J., Selby, R. & Starzl, T.E. (1991) Adverse effects associated with the use of FK 506. Transplantation Proceedings, 23, 31053108.
  • Furukawa, M., Terae, S., Chu, B.C., Kaneko, K., Kamada, H. & Miyasaka, K. (2001) MRI in seven cases of tacrolimus (FK-506) encephalopathy: utility of FLAIR and diffusion-weighted imaging. Neuroradiology, 43, 615621.
  • Garg, R.K. (2001) Posterior leukoencephalopathy syndrome. Postgraduate Medical Journal, 77, 2428.
  • Grimbert, P., Azema, C., Pastural, M., Dhamane, D., Remy, P., Salomon, L., Schortgen, F., Baron, C. & Lang, P. (1999) Tacrolimus (FK506)-induced severe and late encephalopathy in a renal transplant recipient. Nephrology, Dialysis, Transplantation, 14, 24892491.
  • Jain, A.B., Fung, J.J., Todo, S., Reyes, J., Selby, R., Irish, W., Doyle, H., Abu-Elmagd, K., Casavilla, A., Nour, B., Bronsther, O., Jabbour, N., Pinna, A., Dodson, F., Ramos, H., McMichael, J.J., McCauley, J., Tzakis, A.G., Marino, I., Marsh, W., Venkataramanan, R., Iwatsuki, S. & Starzl, T.E. (1995) One thousand consecutive primary orthotopic liver transplants under FK 506: survival and adverse events. Transplantation Proceedings, 27, 10991104.
  • Misawa, A., Takeuchi, Y., Hibi, S., Todo, S., Imashuku, S. & Sawada, T. (2000) FK506-induced intractable leukoencephalopathy following allogeneic bone marrow transplantation. Bone Marrow Transplantation, 25, 331334.
  • Mori, A., Tanaka, J., Kobayashi, S., Hashino, S., Yamamoto, Y., Ota, S., Asaka, M. & Imamura, M. (2000) Fatal cerebral hemorrhage associated with cyclosporin-A/FK506-related encephalopathy after allogeneic bone marrow transplantation. Annals of Hematology, 79, 588592.
  • Parvex, P., Pinsk, M., Bell, L.E., O'Gorman, A.M., Patenaude, Y.G. & Gupta, I.R. (2001) Reversible encephalopathy associated with tacrolimus in pediatric renal transplants. Pediatric Nephrology, 16, 537542.
  • Schwartz, R.B., Bravo, S.M., Klufas, R.A., Hsu, L., Barnes, P.D., Robson, C.D. & Antin, J.H. (1995) Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases. American Journal of Roentgenology, 165, 627631.
  • Singh, N., Bonham, A. & Fukui, M. (2000) Immunosuppressive-associated leukoencephalopathy in organ transplant recipients. Transplantation, 69, 467472.
  • Steg, R.E., Kessinger, A. & Wszolek, Z.K. (1999) Cortical blindness and seizures in a patient receiving FK506 after bone marrow transplantation. Bone Marrow Transplantation, 23, 959962.
  • The U.S. Multicenter FK506 Liver Study Group (1994) A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation. New England Journal of Medicine, 331, 11101115.
  • Thompson, C.B., June, C.H., Sullivan, K.M. & Thomas, E.D. (1984) Association between cyclosporin neurotoxicity and hypomagnesaemia. Lancet, 2, 11161120.
  • Wijdicks, E.F., Wiesner, R.H., Dahlke, L.J. & Krom, R.A. (1994) FK506-induced neurotoxicity in liver transplantation. Annals of Neurology, 35, 498501.